 Hi, everyone, my name is Jenny and I'm a sub-facilitator and I'm a student in Public Health University in Cook. So my working title is for work placement of COVID-19 vaccine in Asia. So on the left side of the figure there, you can see that the top three vaccines that being used are based on the number of doses. So the first one is coronavirus, which is inactivated vaccine and Pfizer, which is mRNA vaccine, and Xenopharm is also inactivated vaccine. So doing more inactivated vaccines on the right figure, you can see that Indonesia is the second country outside of China that may need this type of vaccine. So the effectiveness of inactivated vaccine has been shown to be poorer compared to other type of vaccines such as mRNA, and however, they have really good effectiveness. Okay, so where did this come from? So my project is interested to look at the immune responses that are generated following the inactivated vaccine. And it is thought that he thought that the immune response that has been presented several before, that is quite important for him. So for my research, first I'm going to do a systematic review to understand more of the T-cell responses. And secondly, I'm going to shift samples from Indonesia, so these are people who have been vaccinated either with inactivated vaccines or mRNA or a factor vaccine, and to compare their responses. And also to compare the responses with people in the UK. And because Indonesia has very strict regulation in material transfer agreement, so it will take some time for the sample to get here. So my pattern project, I'm interested to look at more immune responses in people who today haven't been infected with COVID. So if anyone in this group belongs to this category and are willing to volunteer, please come. Thank you.